Literature DB >> 19730871

Hip resurfacing and osteonecrosis: results from an independent hip resurfacing register.

Tajeshwar S Aulakh1, Chandra Rao, Jan-Herman Kuiper, James B Richardson.   

Abstract

INTRODUCTION: Single surgeon studies from specialized centers have suggested that metal-on-metal hip resurfacing in patients with osteonecrosis of hip joint provides good implant survival and function.
METHOD: We tested the hypothesis that multicenter results of hip resurfacing, in terms of function and survival, are similar between patients with osteoarthritis and osteonecrosis. PATIENTS: 192 patients (202 hips) underwent metal-on-metal hip resurfacing at different centers around the world. We compared the revision risks in 95 patients (101 hips) with osteonecrosis and 97 patients (101 hips) with osteoarthritis.
RESULTS: The mean age at operation was 42 and 43 years and the preoperative and postoperative Harris hip scores were 62 and 96 and 58 and 95 for osteonecrosis and osteoarthritis groups. Survival with revision for any reason as the end point at last follow-up was 97.7% for osteonecrosis and 95.0% for osteoarthritis.
CONCLUSION: We conclude that hip resurfacing can be offered to patients with osteonecrosis.

Entities:  

Mesh:

Year:  2010        PMID: 19730871     DOI: 10.1007/s00402-009-0963-0

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  9 in total

1.  Revision rate of Birmingham Hip Resurfacing arthroplasty: comparison of published literature and arthroplasty register data.

Authors:  Reinhard Schuh; Daniel Neumann; Rauend Rauf; Jochen Hofstaetter; Nikolaus Boehler; Gerold Labek
Journal:  Int Orthop       Date:  2012-02-22       Impact factor: 3.075

2.  Hip resurfacing in patients who have osteonecrosis and are 25 years or under.

Authors:  Siraj A Sayeed; Aaron J Johnson; D Alex Stroh; Thomas P Gross; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

Review 3.  Hip resurfacing: a systematic review of literature.

Authors:  Régis Pailhé; Akash Sharma; Nicolas Reina; Etienne Cavaignac; Philippe Chiron; Jean-Michel Laffosse
Journal:  Int Orthop       Date:  2012-10-26       Impact factor: 3.075

4.  Hip resurfacing arthroplasty for osteonecrosis of the femoral head: Implant-specific outcomes and risk factors for failure.

Authors:  Chan-Woo Park; Seung-Jae Lim; Joo-Hwan Kim; Youn-Soo Park
Journal:  J Orthop Translat       Date:  2020-01-06       Impact factor: 5.191

Review 5.  Metal-on-metal hip resurfacing arthroplasty: an analysis of safety and revision rates.

Authors:  S Sehatzadeh; K Kaulback; L Levin
Journal:  Ont Health Technol Assess Ser       Date:  2012-08-01

Review 6.  Metal-on-Metal Bearing: Is This the End of the Line? We Do Not Think So.

Authors:  Henri Migaud; Sophie Putman; Antoine Combes; Charles Berton; Donatien Bocquet; Laurent Vasseur; Julien Girard
Journal:  HSS J       Date:  2012-09-11

Review 7.  Hip resurfacing versus total hip arthroplasty: a systematic review comparing standardized outcomes.

Authors:  Deborah A Marshall; Karen Pykerman; Jason Werle; Diane Lorenzetti; Tracy Wasylak; Tom Noseworthy; Donald A Dick; Greg O'Connor; Aish Sundaram; Sanne Heintzbergen; Cy Frank
Journal:  Clin Orthop Relat Res       Date:  2014-04-04       Impact factor: 4.176

8.  Preliminary results of implantation in animal model and osteoblast culture evaluation of prototypes of biomimetic multispiked connecting scaffold for noncemented stemless resurfacing hip arthroplasty endoprostheses.

Authors:  Ryszard Uklejewski; Piotr Rogala; Mariusz Winiecki; Andrzej Kędzia; Piotr Ruszkowski
Journal:  Biomed Res Int       Date:  2013-07-29       Impact factor: 3.411

Review 9.  Prevalence of Failure due to Adverse Reaction to Metal Debris in Modern, Medium and Large Diameter Metal-on-Metal Hip Replacements--The Effect of Novel Screening Methods: Systematic Review and Metaregression Analysis.

Authors:  Aleksi Reito; Olli Lainiala; Petra Elo; Antti Eskelinen
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.